NCT05132699View on ClinicalTrials.gov

Enhancing Prolonged Exposure With Cannabidiol to Treat Posttraumatic Stress Disorder

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

April 4, 2022

Primary Completion Date

June 30, 2023

Study Completion Date

June 30, 2023

Conditions
Posttraumatic Stress DisorderStress Disorders, Post-Traumatic
Interventions
DRUG

Cannabidiol (CBD) oral solution

An oral strawberry flavored liquid, taken as a 2.5ml (250mg) dose twice a day

DRUG

Placebo

An inert strawberry flavored oral solution, taken as a 2.5ml dose twice a day

BEHAVIORAL

Massed Prolonged Exposure (mPE)

mPE, delivered daily Monday through Friday over two weeks, utilizes exposure-based interventions to target psychological mechanisms (i.e., experiential and behavioral avoidance; maladaptive cognitive changes) that are thought to maintain trauma-related symptoms.

Trial Locations (1)

78229

University of Texas Health Science Center at San Antonio - STRONG STAR Northwest Center, San Antonio

All Listed Sponsors
collaborator

National Center for Advancing Translational Sciences (NCATS)

NIH

lead

The University of Texas Health Science Center at San Antonio

OTHER